← sources

US FDA rulemaking: Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software

source: gov (gov:us_fda)published 2026-09-11 04:00ingested 2026-09-12 02:35

retained text

The Food and Drug Administration (FDA) is classifying the cardiovascular machine learning-based notification software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cardiovascular machine learning- based notification software. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

document fetched 2026-09-14 02:33 · canonical https://federalregister.gov/documents/2026/09/11/2026-18612/medical-devices-cardiovascular-devices-classification-of-the-cardiovascular-machine-learning-based